InteliCare Secures mecwacare Trial, Boosts Hardware Sales at Hardi Sites

Commercial Expansion with mecwacare

InteliCare Holdings Ltd (ASX: ICR) has taken a significant step forward in the March 2025 quarter by executing a commercial agreement to trial its AI-powered InteliCare platform at mecwacare’s Trescowthick Centre in Prahran, Victoria. This trial, covering 60 residents over three months, marks a key validation of InteliCare’s technology in a large, not-for-profit aged care provider setting. The initial contract includes $212,000 in hardware and implementation fees, reflecting mecwacare’s commitment to exploring smart, data-driven care solutions.

CEO Daniel Pilbrow highlighted the strategic importance of this partnership, noting it as a direct outcome of the company’s successful deployment with Hardi Aged Care. The mecwacare trial aligns with the broader digital transformation trends in aged care, especially as providers prepare for the new Aged Care Act and Support at Home Program changes effective July 2025.

Progress at Hardi Aged Care Sites

InteliCare’s ongoing relationship with Hardi Aged Care continues to deepen, with deployment underway at Hardi’s third facility in Wyoming/Summer Hill and planning well advanced for the fourth site at Seven Hills. The company has already received $240,000 in initial hardware revenues for these two sites, contributing to a total of $702,000 collected out of a $1.7 million hardware and implementation contract. SaaS fees are also beginning to flow from earlier site deployments, indicating a growing recurring revenue stream.

Integration efforts are progressing, with InteliCare working to embed its platform into Hardi’s care management system (Manad) and nurse call system. These integrations are expected to unlock the full capabilities of InteliCare’s predictive analytics and real-time monitoring, enhancing care delivery and operational efficiency.

Innovations in Remote Patient Monitoring

Beyond aged care, InteliCare is advancing remote patient monitoring (RPM) initiatives that demonstrate the platform’s versatility. A 12-month pilot with North Shore GP in Townsville is actively monitoring chronic heart failure patients, with early interventions already preventing hospital admissions. Similarly, in Brunei, a partnership with Specialist Direct Pty Ltd has completed Phase 1 of a pilot targeting obesity, Parkinson’s disease, and post-stroke recovery cohorts, with high satisfaction reported by patients and care teams.

These pilots underscore InteliCare’s potential to extend its technology into broader healthcare settings, supporting virtual care models and chronic disease management, which are increasingly critical in modern health systems.

Product Development and Regulatory Alignment

InteliCare has focused on enhancing its platform’s interoperability by developing standardized connectors for leading care management and nurse call systems. This positions the platform as a seamless component within residential aged care ecosystems, reducing manual data entry and improving care event detection. These capabilities are particularly timely given the compliance and reporting demands introduced by the new Aged Care Act.

Such integrations not only improve operational workflows but also enable richer resident analytics, supporting personalised care decisions and regulatory adherence.

Financial Position and Outlook

Financially, InteliCare reported sales receipts of $413,000 for the quarter, more than doubling the prior quarter’s $177,000. The company ended March 2025 with $794,000 in cash and continues to manage expenses prudently, with key costs including staff, administration, and product manufacturing. While well-funded for current operations, maintaining cash discipline remains a priority as the company scales its commercial activities.

Looking ahead, InteliCare’s ability to convert its growing commercial pipeline into sustained revenue streams will be critical, especially as the aged care sector navigates regulatory shifts and cost pressures that drive demand for innovative care technologies.